Home/Filings/4/0001731122-25-000779
4//SEC Filing

WILD HANS PETER 4

Accession 0001731122-25-000779

CIK 0001771910other

Filed

May 18, 8:00 PM ET

Accepted

May 19, 3:52 PM ET

Size

5.2 KB

Accession

0001731122-25-000779

Insider Transaction Report

Form 4
Period: 2025-05-15
Transactions
  • Other

    Common Shares

    2025-05-15+9,788,9449,788,944 total
Footnotes (1)
  • [F1]Dr. Hans-Peter Wild ("Dr. Wild") holds a portion of the shares directly and another portion indirectly via HP Wild Holding AG ("HPW Holding") and HPWH TH AG ("HPWH"). The principal business of HPWH is holding investment rights in, directly or indirectly, ADCT. HPW Holding is an intermediary holding company and Dr. Wild is the Chairman of HPW Holding and HPWH. Thomas Pfisterer was a member of the Board of HPWH and held a total of 451,856 shares directly or indirectly in HPWH, but has transferred such ownership by way of an intragroup sale following Thomas Pfisterer stepping down from the Board of HPWH.

Documents

1 file

Issuer

ADC Therapeutics SA

CIK 0001771910

Entity typeother

Related Parties

1
  • filerCIK 0000905538

Filing Metadata

Form type
4
Filed
May 18, 8:00 PM ET
Accepted
May 19, 3:52 PM ET
Size
5.2 KB